Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

20/20 BIOLABS, INC. (AIDX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

20/20 BIOLABS, INC. (AIDX), most recent 12 months reported: revenue $2.05M, net loss $3.74M. Latest balance sheet on file: liquid cash $4.55M. From SEC filings. Others in Services-Testing Laboratories: UL Solutions Inc. · NeoGenomics, Inc. · Hypha Labs, Inc.

Stock screener

Watchlist